About Peter Vanderklish
Form D filings for Visum Pharma from 2021 to 2023 list Peter Vanderklish as director.
Peter Vanderklish first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Vanderklish in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Vanderklish works with at each company, as listed on that company's latest Form D.
Visum Pharma, Inc. · Form D, Sep 13, 2023
BP
Bernard Peperstraete
Director
JC
John Costantino
Director
AC
Alex Cuomo
Executive officer
WG
William Gedale
President and CEO, director
MS
Mark Smith
Executive officer